What is the recommended reduction in Tresiba (Insulin Degludec) dose after discontinuing D5 (Dextrose 5%) in a patient with blood glucose levels of 125-127 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tresiba Dose Reduction After D5 Discontinuation

Immediate Recommendation

Reduce Tresiba by 4 units (from 20 to 16 units) immediately, given the discontinuation of D5 infusion and current blood glucose levels of 125-127 mg/dL. 1

Rationale for This Specific Reduction

The patient's blood glucose levels overnight (125-127 mg/dL) are already at the lower end of acceptable fasting targets (80-130 mg/dL), and removing the D5 infusion eliminates approximately 120 grams of glucose per 24 hours that was previously requiring insulin coverage 2. A 20% reduction (4 units from 20 units) is the standard approach when discontinuing a continuous glucose source to prevent hypoglycemia 2, 1.

Key Principles for Insulin Adjustment When Stopping Dextrose

  • When discontinuing IV dextrose in hospitalized patients, basal insulin should be reduced by 10-20% immediately to prevent hypoglycemia 2, 1

  • The 20% reduction rule applies specifically when removing a continuous carbohydrate source - D5 at 100 mL/hr provides continuous glucose that was being covered by the current Tresiba dose 2

  • Blood glucose values of 125-127 mg/dL indicate the current regimen is already achieving tight control, making the patient vulnerable to hypoglycemia once the glucose infusion stops 2

Monitoring Requirements After Adjustment

  • Check blood glucose every 4-6 hours for the first 24 hours after discontinuing D5 to ensure the dose reduction is adequate 2

  • If blood glucose rises above 180 mg/dL consistently, increase Tresiba by 2 units every 3 days until fasting glucose returns to 80-130 mg/dL target 1

  • If blood glucose falls below 70 mg/dL, reduce Tresiba by an additional 2 units (10% further reduction) 2, 1

Critical Pitfall to Avoid

Do not continue the same Tresiba dose after stopping D5 - this is a common error that leads to iatrogenic hypoglycemia in hospitalized patients 2. The continuous glucose infusion was providing substrate that required insulin coverage; removing it without adjusting insulin creates a mismatch that predictably causes hypoglycemia 2.

Alternative Consideration

If the patient has poor or unpredictable oral intake, consider a more conservative reduction to 15 units (25% reduction) rather than 16 units, as elderly patients or those with renal impairment are at higher risk for hypoglycemia 1.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.